Ira Chang
Neurocritical Care Englewood, CO Medical Doctor
NPI 1285645440 CMS profile 240075
499 E Hampden Ave, Suite 360, Englewood, CO 80113
General payments
$15,322
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$39,100
Through program year 2025, Ira Chang of Englewood, CO is reported in the CMS Open Payments database as having received $15,322 across 17 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $39,100 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Neurocritical Care profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $3,570 | 2 | |
| 2024 | General | $5,800 | 3 | |
| 2023 | General | $5,400 | 1 | |
| 2021 | General | $17 | 1 | |
| 2020 | General | $249 | 3 | |
| 2019 | General | $287 | 7 |
Beside peers
- Ira Chang
- Neurocritical Care median
- Middle half of Neurocritical Care
- National median
In program year 2025, general payments to Ira Chang were reported at $3,570. Among 223 Neurocritical Care profiles paid that year, the median was $98 and the middle half received between $34 and $262.
Show as a table
| Year | Ira Chang | Neurocritical Care median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $287 | $125 | $47–$286 | $163 |
| 2020 | $249 | $74 | $21–$153 | $114 |
| 2021 | $17 | $108 | $34–$250 | $132 |
| 2022 | $0 | $115 | $31–$277 | $149 |
| 2023 | $5,400 | $127 | $35–$275 | $160 |
| 2024 | $5,800 | $127 | $44–$265 | $164 |
| 2025 | $3,570 | $98 | $34–$262 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 15 billing codesPaid by Medicare
$54,126
Medicare patients
234
Services billed
454
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 47% | |
| Diabetes | 40% | |
| Atrial fibrillation | 39% | |
| Depression | 38% | |
| Ischemic heart disease | 37% | |
| Chronic kidney disease | 35% | |
| Heart failure | 30% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
17 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurocritical Care in Colorado
Luis Cava Prado
Neurocritical Care · Aurora, CO
Malissa Pynes
Neurocritical Care · Greenwood Village, CO
Chamisa MacIndoe
Neurocritical Care · Colorado Springs, CO
Robert Neumann
Neurocritical Care · Aurora, CO
Jason Weedman
Neurocritical Care · Aurora, CO
Kourosh Kahkeshani
Neurocritical Care · Greenwood Village, CO
Related records
Neurocritical Care in Colorado
Practitioners in the same specialty and state, ranked by reported value.
All Neurocritical Care
Everyone recorded under this specialty, nationwide.
Doctors in Colorado
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.